Rossari Biotech Unitop Chemicals Arbitration Dispute Update

Rossari Biotech Limited is involved in a legal challenge concerning the acquisition of Unitop Chemicals Private Limited. The company received a petition on June 4, 2026, filed by the sellers under Section 34 of the Arbitration and Conciliation Act, 1996. This petition challenges the final arbitration award that was issued on January 21, 2026.

What just happened

The sellers of Unitop Chemicals Private Limited have filed a Section 34 petition challenging the January 21, 2026, arbitration award. This action was served to Rossari Biotech on June 4, 2026.

Why this matters

This legal challenge means the resolution of the dispute regarding the acquisition of the material unlisted subsidiary, Unitop Chemicals, is not final. It introduces ongoing legal uncertainty and potential further proceedings.

The backstory

The dispute stems from a Share Purchase Agreement (SPA) dated June 2, 2021, for the acquisition of Unitop Chemicals. An arbitration proceeding was initiated on December 13, 2023, culminating in a final award on January 21, 2026.

What changes now

The matter will now undergo further review by the courts due to the Section 34 challenge. The finality of the award is pending this judicial process.

Risks to watch

Ongoing legal uncertainty and potential for continued litigation represent key risks for Rossari Biotech.

Investor Takeaway

The acquisition dispute for Unitop Chemicals remains unresolved. Investors should closely monitor legal developments and potential associated costs.